Successful management of rocuronium-induced anaphylaxis with sugammadex: A case report
Although anaphylaxis during anaesthesia is a rare event, neuromuscular blocking drugs are responsible for 62% of anaesthesia-related anaphylaxis. However, sugammadex, a modified gamma-cyclodextrin, can encapsulate rocuronium molecules and cause the rapid reversal of the neuromuscular blockade. A 68-...
Main Authors: | Sheng-Kai Hung, Chia-Chi Yeh, Pei-Chi Ting, Cay-Huyen Chen, Ming-Chang Kao |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-07-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605221113913 |
Similar Items
-
Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
by: Shu Chung Choi, et al.
Published: (2020-08-01) -
Treatment of rocuronium-induced anaphylaxis using sugammadex - A case report -
by: Sun-Min Kim, et al.
Published: (2021-01-01) -
Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
by: Ismar Lima Cavalcanti, et al.
Published: (2021-01-01) -
Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
by: Ismar Lima Cavalcanti, et al.
Published: (2020-11-01) -
Rocuronium-Sugammadex in Anesthesia for Electroconvulsive Therapy
by: Nilay Tas, et al.
Published: (2016-03-01)